Home » Newsletters » BioWorld

BioWorld

Jan. 21, 1993

View Archived Issues

IMAGING AGENT DETECTS LESIONS

ISIS COMPLETES OFFERING

CHEMEX COMPLETES ADDITIONAL TRIALS

FDA APPROVES ONCOR ASSAY

APPOINTMENTS AND ADVANCEMENTS

ESCAGENETICS COLLABORATES WITH GENENCOR

IMMUNE RESPONSE FILES IND

GTI TO CO-DEVELOP CANCER THERAPIES

LILLY TO WRITE OFF CENTOCOR EXPENSES

RECOMBINANT ANTI-TUMOR TOXIN

VESTAR SUES LTI OVER LIPOSOME PATENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...